SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-23-065522
Filing Date
2023-11-21
Accepted
2023-11-21 16:30:38
Documents
2
Period of Report
2023-11-15

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1605
2 EX-24.1 amrn-ex24_1.htm EX-24.1 10846
  Complete submission text file 0000950170-23-065522.txt   14110
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Issuer) CIK: 0000897448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMARIN CORPORATION PLC 77 SIR JOHN ROGERSON'S QUAY, BLOCK C DUBLIN L2 D02 VK60
Business Address
Provoost Jonathan (Reporting) CIK: 0001998452 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-21392 | Film No.: 231428607